Nanomedicines for delivery across the blood-brain barrier
Lalatsa, Aikaterini and Das, Debanjan and Osouli-Bostanabad, Karim; Uchegbu, Ijeoma F. and Schatzlein, Andreas G., eds. (2024) Nanomedicines for delivery across the blood-brain barrier. In: Fundamentals of Pharmaceutical Nanoscience. Springer Publishing, New York. ISBN 9783031594779 (In Press)
Text.
Filename: Lalatsa_etal_FPN_2023_Nanomedicines_for_delivery_across_the_blood_brain_barrier.pdf
Accepted Author Manuscript Restricted to Repository staff only until 1 January 2099. License: Strathprints license 1.0 Download (1MB) | Request a copy |
Abstract
Central nervous system (CNS) disorders affect one in three worldwide and represent a large unmet medical need involving chronic conditions such as Alzheimer’s and Parkinson’s disease, stroke, brain tumours, migraine, pain, and mental diseases. CNS drug development is hampered by the restricted drug and biological transport across an anatomical barrier, the blood-brain barrier. Many brain tumours and neurological diseases can greatly benefit from the use of emerging nanotechnologies based on targeted nanomedicines that are able to noninvasively transport highly potent and specific pharmaceuticals across the blood–brain barrier. In this chapter, we will discuss blood-to-brain drug delivery strategies using nanocarriers such as polymeric and lipid-based strategies with a focus on the mechanism of permeation, pharmaceutical, pharmacokinetic/pharmacodynamic and regulatory and clinical aspects of their development. Although it remains unrealistic to expect a magic bullet for brain central nervous system delivery, nanomedicines are the only technologies to date to have shown considerable promise for these patients with chronic and devastating brain diseases.
ORCID iDs
Lalatsa, Aikaterini ORCID: https://orcid.org/0000-0003-4791-7468, Das, Debanjan and Osouli-Bostanabad, Karim ORCID: https://orcid.org/0000-0003-4375-4948; Uchegbu, Ijeoma F. and Schatzlein, Andreas G.-
-
Item type: Book Section ID code: 84071 Dates: DateEvent23 December 2024Published31 January 2023AcceptedSubjects: Medicine > Therapeutics. Pharmacology
Technology > Engineering (General). Civil engineering (General) > BioengineeringDepartment: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 08 Feb 2023 02:03 Last modified: 11 Nov 2024 15:32 URI: https://strathprints.strath.ac.uk/id/eprint/84071